Treatment Of Igan clinical trials

Explore recruiting treatment of igan clinical trials.

Recruiting treatment of igan studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Treatment Of Igan trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Multicenter, Rollover Study to Evaluate the Long-Term Safety and Efficacy of Atacicept

Belgium, Germany, Greece, Czechia, Poland, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2/3, Multicenter, Open‑label Trial to Evaluate the Long‑term Safety, Tolerability, and Efficacy of Sibeprenlimab Administered Subcutaneously in Subjects with Immunoglobulin A Nephropathy.

Spain, Belgium, Croatia, Czechia, France, Germany +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

A multi-center, randomized, double-blind, placebo-controlled, parallel group, phase III study to evaluate the efficacy and safety of LNP023 in primary IgA nephropathy patients

Italy, Netherlands, Belgium, Hungary, Slovenia, Spain +6 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Sefaxersen, an Antisense Inhibitor of Complement Factor B, in Patients with Primary IgA Nephropathy at High Risk of Progression

France, Greece, Czechia, Germany, Italy, Spain +1 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Treatment Of Igan trials by city

Treatment Of Igan in Toronto Treatment Of Igan in Vancouver Treatment Of Igan in Montreal Treatment Of Igan in Calgary Treatment Of Igan in Edmonton Treatment Of Igan in Ottawa Treatment Of Igan in Winnipeg Treatment Of Igan in Quebec City Treatment Of Igan in Hamilton Treatment Of Igan in Kitchener Treatment Of Igan in London Treatment Of Igan in Halifax Treatment Of Igan in New York Treatment Of Igan in Los Angeles Treatment Of Igan in Chicago Treatment Of Igan in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease